American Well Co. (NYSE:AMWL) Sees Large Increase in Short Interest

American Well Co. (NYSE:AMWL - Get Free Report) was the target of a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 383,100 shares, a growth of 7.9% from the January 15th total of 355,000 shares. Approximately 3.3% of the company's shares are sold short. Based on an average trading volume of 58,900 shares, the days-to-cover ratio is presently 6.5 days.

American Well Stock Down 2.6 %

AMWL stock traded down $0.32 during trading hours on Friday, hitting $11.74. The company's stock had a trading volume of 78,005 shares, compared to its average volume of 89,314. The company has a market capitalization of $183.32 million, a PE ratio of -0.84 and a beta of 1.18. American Well has a 12 month low of $5.00 and a 12 month high of $23.80. The stock has a 50 day moving average price of $9.57 and a two-hundred day moving average price of $9.25.

American Well (NYSE:AMWL - Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported ($2.77) EPS for the quarter, topping the consensus estimate of ($3.04) by $0.27. American Well had a negative net margin of 81.83% and a negative return on equity of 56.73%. Sell-side analysts expect that American Well will post -9.34 earnings per share for the current year.

Institutional Trading of American Well

Large investors have recently added to or reduced their stakes in the business. Compagnie Lombard Odier SCmA bought a new stake in American Well in the fourth quarter worth approximately $45,000. OMERS ADMINISTRATION Corp bought a new stake in shares of American Well during the 4th quarter worth $76,000. BNP Paribas Financial Markets bought a new stake in shares of American Well during the 3rd quarter worth $95,000. PDT Partners LLC bought a new stake in shares of American Well during the 3rd quarter worth $107,000. Finally, Corton Capital Inc. bought a new stake in shares of American Well during the 4th quarter worth $134,000. 56.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on AMWL. Morgan Stanley dropped their price objective on shares of American Well from $20.00 to $10.50 and set an "equal weight" rating on the stock in a research note on Tuesday, December 17th. Stifel Nicolaus upped their price objective on shares of American Well from $9.00 to $10.00 and gave the company a "hold" rating in a research note on Thursday, February 13th. Needham & Company LLC reiterated a "hold" rating on shares of American Well in a research note on Thursday, February 13th. Wells Fargo & Company upgraded shares of American Well from an "equal weight" rating to an "overweight" rating and set a $15.00 price objective on the stock in a research note on Monday, January 13th. Finally, Truist Financial upped their price objective on shares of American Well from $10.00 to $12.00 and gave the company a "hold" rating in a research note on Friday, February 14th. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $11.90.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.